C. Caldas

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial

N. A. Walton, M. J. Irwin, J. D. Brenton, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer

Y. Wang, I. O. Ellis, S. Tavare, 2007 .